Doravirine
Brand name: Pifeltro
Rank #370 of 500 drugs by total cost
$26.4M
Total Cost
14,437
Total Claims
$26.4M
Total Cost
481
Prescribers
$1,827
Cost per Claim
478
Beneficiaries
14,995
30-Day Fills
$55K
Avg Cost/Provider
30
Avg Claims/Provider
About Doravirine
Doravirine (sold as Pifeltro) was prescribed 14,437 times by 481 Medicare Part D providers in 2023, costing the program $26.4M. At $1,827 per claim, this is a high-cost medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 367 | Plecanatide (Trulance) | $26.6M | 36,026 |
| 368 | Ursodiol (Ursodiol) | $26.6M | 123,719 |
| 369 | Glycerol Phenylbutyrate (Ravicti) | $26.6M | 268 |
| 370 | Doravirine (Pifeltro) | $26.4M | 14,437 |
| 371 | Brinzolamide/Brimonidine Tart (Simbrinza) | $26.3M | 97,240 |
| 372 | Rotigotine (Neupro) | $26.2M | 23,665 |
| 373 | Chlorpromazine Hcl (Chlorpromazine Hcl) | $25.9M | 78,710 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology